XML 93 R76.htm IDEA: XBRL DOCUMENT v3.20.4
Stock-Based Compensation, Stock Options (Details) - USD ($)
$ / shares in Units, $ in Thousands
12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Number of Shares [Roll Forward]      
Exercised (in shares) (400,000) 0 (500,000)
Stock Options [Member]      
Number of Shares [Roll Forward]      
Outstanding at beginning of year (in shares) 3,120,900    
Granted (in shares) 1,079,300    
Exercised (in shares) (230,900)    
Forfeited/cancelled/expired (in shares) (800,700)    
Outstanding at end of year (in shares) 3,168,600 3,120,900  
Exercisable at end of year (in shares) 1,336,300    
Weighted-Average Exercise Price [Roll Forward]      
Outstanding at beginning of year (in dollars per share) $ 55.38    
Granted (in dollars per share) 30.45    
Exercised (in dollars per share) 31.97    
Forfeited/cancelled/expired (in dollars per share) 70.55    
Outstanding at end of year (in dollars per share) 44.76 $ 55.38  
Exercisable at end of year (in dollars per share) $ 43.18    
Remaining Contractual Term and Aggregate Intrinsic Value [Abstract]      
Outstanding options, weighted-average remaining contractual term 4 years 2 months 12 days    
Outstanding options, aggregate intrinsic value $ 45,130    
Exercisable options, weighted-average remaining contractual term 2 years 5 months 23 days    
Exercisable options, aggregate intrinsic value $ 19,124    
Service-Based Options [Member]      
Number of Shares [Roll Forward]      
Outstanding at beginning of year (in shares) 962,500    
Granted (in shares) 0    
Exercised (in shares) (114,700)    
Forfeited/cancelled/expired (in shares) (77,200)    
Outstanding at end of year (in shares) 770,600 962,500  
Exercisable at end of year (in shares) 770,600    
Weighted-Average Exercise Price [Roll Forward]      
Outstanding at beginning of year (in dollars per share) $ 41.11    
Granted (in dollars per share) 0    
Exercised (in dollars per share) 32.82    
Forfeited/cancelled/expired (in dollars per share) 77.39    
Outstanding at end of year (in dollars per share) 38.71 $ 41.11  
Exercisable at end of year (in dollars per share) $ 38.71    
Remaining Contractual Term and Aggregate Intrinsic Value [Abstract]      
Outstanding options, weighted-average remaining contractual term 2 years 21 days    
Outstanding options, aggregate intrinsic value $ 13,410    
Exercisable options, weighted-average remaining contractual term 2 years 21 days    
Exercisable options, aggregate intrinsic value $ 13,410    
Performance-Based Options [Member]      
Number of Shares [Roll Forward]      
Outstanding at beginning of year (in shares) 2,158,400    
Granted (in shares) 1,079,300    
Exercised (in shares) (116,200)    
Forfeited/cancelled/expired (in shares) (723,500)    
Outstanding at end of year (in shares) 2,398,000.0 2,158,400  
Exercisable at end of year (in shares) 565,600    
Weighted-Average Exercise Price [Roll Forward]      
Outstanding at beginning of year (in dollars per share) $ 61.75    
Granted (in dollars per share) 30.45    
Exercised (in dollars per share) 31.13    
Forfeited/cancelled/expired (in dollars per share) 69.82    
Outstanding at end of year (in dollars per share) 46.71 $ 61.75  
Exercisable at end of year (in dollars per share) $ 49.26    
Remaining Contractual Term and Aggregate Intrinsic Value [Abstract]      
Outstanding options, weighted-average remaining contractual term 4 years 10 months 20 days    
Outstanding options, aggregate intrinsic value $ 31,720    
Exercisable options, weighted-average remaining contractual term 3 years 18 days    
Exercisable options, aggregate intrinsic value $ 5,713